tiprankstipranks
Trending News
More News >
Kuros Biosciences Ltd. (CSBTF)
OTHER OTC:CSBTF
US Market

Kuros Biosciences (CSBTF) Financial Statements

Compare
13 Followers

Kuros Biosciences Financial Overview

Kuros Biosciences's market cap is currently $1.16B. The company's EPS TTM is $0.11797012800000001; its P/E ratio is 498.59; Kuros Biosciences is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueCHF 121.30MCHF 75.56MCHF 33.56MCHF 17.99MCHF 13.81M
Gross ProfitCHF 104.79MCHF 62.03MCHF 23.94MCHF 10.77MCHF 10.07M
Operating IncomeCHF 7.33MCHF -5.00MCHF -13.19MCHF -13.45MCHF -8.77M
EBITDACHF 10.13MCHF -561.00KCHF -6.84MCHF -8.84MCHF -5.29M
Net IncomeCHF 2.12MCHF -3.72MCHF -13.73MCHF -14.60MCHF -7.54M
Balance Sheet
Cash & Short-Term InvestmentsCHF 15.66MCHF 17.46MCHF 14.21MCHF 24.07MCHF 28.62M
Total AssetsCHF 107.21MCHF 84.54MCHF 71.46MCHF 82.95MCHF 91.34M
Total DebtCHF 3.94MCHF 1.79MCHF 2.14MCHF 1.91MCHF 8.93M
Net DebtCHF -11.72MCHF -15.67MCHF -12.06MCHF -22.15MCHF -19.70M
Total LiabilitiesCHF 40.28MCHF 25.79MCHF 14.75MCHF 14.09MCHF 14.36M
Stockholders' EquityCHF 66.93MCHF 58.75MCHF 56.71MCHF 68.86MCHF 76.98M
Cash Flow
Free Cash FlowCHF -2.40MCHF 2.03MCHF -9.17MCHF -7.75MCHF -5.83M
Operating Cash FlowCHF -377.87KCHF 3.14MCHF -8.84MCHF -7.35MCHF -5.45M
Investing Cash FlowCHF -2.03MCHF -1.11MCHF -326.00KCHF -400.00KCHF -374.00K
Financing Cash FlowCHF 1.17MCHF 1.34MCHF -171.00KCHF 3.22MCHF 6.08M
Currency in CHF

Kuros Biosciences Earnings and Revenue History

Kuros Biosciences Debt to Assets

Kuros Biosciences Cash Flow

Kuros Biosciences Forecast EPS vs Actual EPS